Halozyme Therapeutics, Inc. (HALO) Q1 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon. My name is Bailey and I will be your conference operator today. At this time, I would like to welcome everyone to Halo Zyme's first quarter 2025 financial and operating results conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star followed by the number one on your telephone keypad. If you would like to withdraw your question, again, press star and one. Please note, this event is being recorded. I will now turn the call over to Trom Bui, Halozyme's Vice President of Investor Relations in Corporate Communications. Please go ahead. Thank you, Operator. Good afternoon, and welcome to our first quarter 2025 Financial and Operating Results Conference call. In addition to the press release issued today after the market closed, We could find a supplementary slide presentation that would be referenced during today's call in the investor relations section of our website. Leading the call will be Dr. Helen Torley, Halazan's President and Chief Executive Officer, who will provide an update on our business, and Nicole Labrosse, our Chief Financial Officer, who will review our financial results as well as our outlook. On today's call, we will be making forward-looking statements as outlined on slide two. I would also refer you to our SEC filing for a full list of risks and uncertainties. During the call, both GAAP and non-GAAP financial measures will be discussed. Certain non-GAAP or adjusted financial measures are reconciled with the comparable GAAP financial measures in our earnings press release and slide presentation. I will now turn the call over to Dr. Helen Torley. Good afternoon, ev...